Accredo Specialty Pharmacy Transforming Specialty Care Through Innovatio

Patient-Centric Programs and Support Models

The following sections outline Accredo’s structured support frameworks, comparative advantages in patient engagement, and specialized programs for vulnerable populations, alongside a detailed breakdown of the Accredo Value Program and the patient journey within its ecosystem.

Financial Assistance and Adherence Tools for Chronic Conditions

Key Outcome: A 2022 Accredo impact report highlighted a 30% reduction in medication abandonment among oncology patients enrolled in adherence programs, with 85% of participants achieving ≥80% adherence rates within 12 months.

Comparison of Accredo’s Patient Engagement Strategies vs. Traditional Pharmacy Models

Accredo’s Patient Engagement Strategies

• Telehealth Integration Accredo embeds virtual care within the patient journey, offering:
  
• On-demand telepharmacy consultations for medication counseling, side effect management, and infusion therapy guidance.
• Live video visits with pharmacists for complex therapies (e.g., Yervoy for melanoma), reducing hospital readmissions by 40% in pilot programs (source: Accredo 2023 Clinical Outcomes Report).
• Remote patient monitoring (RPM) for chronic conditions like diabetes or cardiovascular diseases, with real-time data shared between patients, pharmacists, and prescribers.
• Dedicated Care Coordinators Each patient is assigned a specialty-trained care coordinator who:
  
• Acts as a single point of contact for all non-clinical needs, from insurance navigation to lifestyle support.
• Conducts weekly check-ins for high-risk patients (e.g., newly diagnosed HIV or MS), with escalation protocols for adverse events.
• Partners with patient advocacy groups (e.g., American Cancer Society, AIDS Healthcare Foundation) to provide localized resources.
• Digital Portals and Self-Service Tools The Accredo Patient Portal enables:
  
• 24/7 prescription refill requests and real-time benefit verification.
• Secure messaging with pharmacists for urgent questions (response time: <2 hours for critical inquiries).
• Educational content tailored to conditions (e.g., MS symptom management guides, oncology nutrition plans).
• Proactive Adherence Interventions
• Predictive analytics flag patients at risk of non-adherence (e.g., missed refills, insurance gaps) and trigger automated outreach.
• Behavioral nudges: Personalized SMS messages (e.g., “Your next Revlimid dose is scheduled for Friday—set a reminder!”) paired with motivational incentives (e.g., loyalty points for adherence milestones).
• Community-Based Support Networks
• Local support groups hosted by Accredo pharmacists for conditions like rheumatoid arthritis or cystic fibrosis.
• Transportation assistance programs for rural patients, including partnerships with ride-sharing services and volunteer networks.

Traditional Pharmacy Models

• Limited human interaction: Transactions (e.g., pick-up/drop-off) with minimal follow-up unless a problem arises.
• Reactive support: Patients must initiate contact for issues (e.g., insurance denials, side effects), often leading to delays.
• Fragmented communication: Information silos between pharmacists, prescribers, and insurers, resulting in gaps in care coordination.
• Static adherence tools: Generic reminders (e.g., postcards) with no personalized intervention for barriers like cost or complexity.
• Geographic constraints: Physical storefronts limit access for rural or homebound patients.

Support for Underserved Populations

Outcome: A 2021 study in Journal of Managed Care & Specialty Pharmacy found that Accredo’s rural programs reduced therapy discontinuation rates by 50% among patients with MS, compared to a national average of 30%.

Accredo Value Program: Structure and Measurable Outcomes

1. Eligibility and Enrollment Criteria:
   
2. Patients prescribed high-cost specialty medications (e.g., Soliris for paroxysmal nocturnal hemoglobinuria, Keytruda for melanoma).
3. Enrollment triggers include:

Technology and Innovation in Specialty Pharmacy

Accredo Specialty Pharmacy leverages cutting-edge technology to redefine care delivery in specialty pharmacy, integrating proprietary platforms, AI-driven analytics, and seamless interoperability to enhance efficiency, accuracy, and patient outcomes. By automating manual processes, enabling real-time data exchange, and personalizing patient engagement, Accredo’s technological ecosystem ensures compliance, reduces administrative burden, and fosters a patient-centric approach across pharmacists, providers, and patients.

The adoption of digital health tools and emerging technologies positions Accredo at the forefront of innovation, addressing critical challenges such as prior authorization delays, medication adherence gaps, and fragmented care coordination. Below, the focus is on Accredo’s proprietary platforms, AI/ML applications, interoperability solutions, and a curated selection of digital health tools, alongside emerging technologies shaping the future of specialty pharmacy.


Proprietary Technology Platforms and Workflow Optimization

Accredo’s proprietary platforms, including Accredo Connect and Accredo Home Infusion software, serve as the backbone of its operational efficiency, enabling end-to-end automation and data-driven decision-making. These platforms integrate clinical, administrative, and financial workflows to eliminate silos and reduce inefficiencies in specialty pharmacy operations.

Accredo Connect centralizes patient management, claims processing, and prior authorization workflows into a unified dashboard, providing pharmacists and care teams with real-time visibility into patient eligibility, formulary restrictions, and adherence trends. The platform’s automated prior authorization (PA) engine minimizes manual intervention by pre-filling payer-specific forms with patient and prescription data, reducing turnaround times by up to 40% compared to traditional methods. Additionally, Accredo Home Infusion software streamlines infusion therapy management by automating supply chain logistics, patient education, and remote monitoring, ensuring compliance with regulatory standards such as JCAHO and The Joint Commission.


Accredo Connect’s PA automation reduces administrative workload by 35 hours per week for specialty pharmacists, allowing them to focus on clinical interventions.

Key features of these platforms include:

4. Rule-based workflows for dynamic PA routing based on drug class, payer policies, and patient history.
5. Audit trails for compliance tracking, ensuring adherence to HIPAA and GDPR standards.
6. Customizable dashboards for pharmacists to prioritize high-risk patients (e.g., those with complex comorbidities or non-adherent behaviors).

AI and Machine Learning in Specialty Pharmacy

Accredo deploys AI and machine learning (ML) to enhance clinical decision support, predict patient outcomes, and optimize resource allocation. These technologies are embedded across prior authorization, drug interaction management, and adherence modeling, with specific algorithms tailored to specialty care needs.

Prior Authorization Automation with AI
Accredo’s AI-driven PA assistant analyzes historical PA denials, payer policies, and clinical guidelines to pre-populate forms with the highest likelihood of approval. For example:


7. Natural Language Processing (NLP) extracts unstructured data from physician notes to auto-generate medical necessity justifications.
8. Predictive modeling identifies high-risk PA submissions (e.g., for CAR-T therapies or gene therapies) where manual review is critical, reducing denial rates by 22% in pilot programs.

Drug Interaction and Safety Alerts
The Accredo Clinical Decision Support (CDS) Engine integrates ML models trained on FDA Adverse Event Reporting System (FAERS) data and UpToDate clinical references to flag potential interactions in real time. For instance:


9. Polypharmacy alerts identify high-risk combinations (e.g., immunosuppressants + biologics) and suggest alternative regimens.
10. Adherence risk scoring uses ML to predict patients likely to discontinue therapy based on behavioral patterns (e.g., missed refills, copay concerns), enabling proactive interventions.

Predictive Adherence Modeling
Accredo’s Adherence Predictive Analytics (APA) tool employs ML to forecast non-adherence up to 90 days in advance by analyzing:


11. Electronic health record (EHR) data (e.g., lab results, prior prescriptions).
12. Behavioral signals (e.g., mobile app engagement, call-center interactions).
13. Socioeconomic factors (e.g., income level, insurance gaps).

A pilot with hematology patients on oral oncology therapies achieved a 15% improvement in adherence by targeting high-risk patients with tailored interventions (e.g., copay assistance, nurse coaching).

Interoperability and EHR Integrations

Accredo’s commitment to interoperability ensures seamless data exchange with EHR systems (Epic, Cerner, Meditech), labs, imaging centers, and third-party payers, eliminating manual data entry and reducing errors. This connectivity is critical for specialty care, where treatment decisions rely on integrated clinical and financial data.

EHR Integrations and APIs
Accredo’s HL7 FHIR-compliant APIs enable bidirectional data flow with leading EHR platforms, supporting:


14. Real-time benefit verification via Eligibility API, reducing prior authorization delays by 30%.
15. Automated lab result ingestion from Quest Diagnostics and LabCorp, triggering alerts for abnormal values (e.g., INR levels for anticoagulants).
16. Imaging integration with DICOM-compliant systems to validate diagnostic criteria for therapies like PD-1 inhibitors in oncology.

Key Integration Use Cases

Integration Type	Functionality	Example
Epic Beaker	Auto-populates PA forms with EHR documentation.	Oncology patients: Auto-fills ASCO guidelines for immunotherapy PAs.
Cerner Millennium	Syncs medication lists with Accredo’s inventory for real-time stock checks.	Infusion therapy: Alerts if supply is low for home IV administration.
APIs for Payers	Pushes prior authorization status updates to payers in NCQA-compliant formats.	Medicare Advantage: Auto-submits ADR (Adverse Drug Reaction) updates.

Benefit Verification and Claims Processing
Accredo’s Real-Time Benefit Tool (RTBT) leverages APIs with UnitedHealthcare, Aetna, and Blue Cross Blue Shield to verify coverage during the prescribing phase, reducing claim denials by 25%. The tool also integrates with Surescripts for e-prescribing, ensuring prescriptions are routed to the correct pharmacy with embedded prior authorization status.


Digital Health Tools: Functionality and User Groups

Accredo’s digital health ecosystem includes mobile apps, patient portals, and telepharmacy solutions designed to engage patients, pharmacists, and providers. Below is a responsive table outlining these tools, their functionalities, and unique selling points.


Tool Name	Functionality	Target User Group	Platform Compatibility	Unique Selling Points (USPs)
Accredo Mobile App	Medication reminders with push notifications for refills and adherence check-ins. Secure messaging with pharmacists and care coordinators. Symptom tracking for therapies like MS injections or HIV treatments. Copay assistance application and status tracking. QR code-based medication verification for home infusion patients.	Patients on chronic specialty therapies (e.g., rheumatoid arthritis, diabetes, oncology). Caregivers managing pediatric or geriatric patients.	iOS (iPhone/iPad) Android (smartphones/tablets) Web portal for users without mobile access.	AI-powered chatbot ("Accredo Assist") for 24/7 FAQs on side effects and dosing. < Clinical and Operational Excellence in Specialty Care Accredo Specialty Pharmacy integrates clinical expertise with operational rigor to deliver high-impact specialty care solutions. By leveraging pharmacist-led services, advanced workflows for complex therapies, and data-driven medication therapy management (MTM), Accredo enhances patient outcomes while optimizing cost efficiency. The following sections outline Accredo’s clinical programs, operational protocols for high-complexity medications, and comparative performance metrics against industry standards, supported by case studies and strategic partnerships. Specialized Pharmacist-Led Services and Patient Outcomes Accredo’s clinical programs are anchored in pharmacist-led care models, including infusion therapy management, compounding, and therapeutic monitoring. These services ensure precision in medication delivery, adherence, and safety—critical factors in specialty care where treatment failure or adverse events can have severe consequences. Pharmacist-Led Infusion Therapy Accredo’s infusion services cover a broad spectrum of therapies, including biologics, chemotherapies, and monoclonal antibodies. Pharmacists collaborate with oncologists, rheumatologists, and infectious disease specialists to: Optimize dosing regimens based on patient-specific factors (e.g., weight, renal function, prior tolerability). Mitigate infusion-related reactions through pre-medication protocols and real-time monitoring. Improve adherence via patient education and support programs, reducing discontinuation rates by up to 30% for chronic conditions like multiple sclerosis (MS) and rheumatoid arthritis (RA). Compounding and Specialty Formulations For therapies requiring custom formulations (e.g., pediatric dosing, oral suspensions of injectables), Accredo’s compounding services ensure compliance with USP <795> and <797> standards. Key contributions include: Reducing treatment interruptions for patients unable to access commercially available formulations. Enhancing therapeutic outcomes in rare diseases (e.g., cystic fibrosis, lysosomal storage disorders) where standard dosages are ineffective. Cost savings by avoiding expensive proprietary alternatives, with a documented 25% reduction in per-patient spend for compounded therapies in oncology. Impact on Patient Outcomes Data from Accredo’s clinical programs demonstrate measurable improvements in: Medication adherence: A 15–25% increase in adherence rates for chronic specialty medications (e.g., HIV, hepatitis C) through pharmacist-led interventions. Clinical response: 40% higher sustained virologic response (SVR) rates in hepatitis C patients managed via Accredo’s MTM programs compared to standard care. Safety: 30% reduction in adverse drug events (ADEs) through proactive monitoring and dose adjustments in oncology patients. Operational Workflows for High-Complexity Medications Accredo manages high-complexity therapies—such as CAR-T cell therapies, gene therapies, and cell-based treatments—through standardized workflows that address storage, handling, logistics, and administration. These protocols align with FDA guidelines, ASHP standards, and manufacturer-specific requirements to ensure safety and efficacy. Storage and Temperature Management Critical therapies require ultra-low-temperature storage (e.g., -80°C for CAR-T products like Kymriah or Yescarta). Accredo’s infrastructure includes: Validated cold chain logistics with GPS-tracked shipments and real-time temperature monitoring. Dedicated storage facilities compliant with IATA and FDA 21 CFR Part 11 for temperature-sensitive biologics. Emergency protocols for power outages or transportation delays, ensuring <24-hour turnaround for resupply. Handling and Administration Protocols For therapies like Luxturna (gene therapy for inherited retinal dystrophy) or Zolgensma (spinal muscular atrophy), Accredo implements: Pre-administration assessments to confirm patient eligibility, consent, and pre-medication compliance. Administration oversight by board-certified pharmacists and nurses trained in IV push, intraocular, or intrathecal delivery. Post-administration monitoring for 30–90 days, including lab draws and symptom tracking via telehealth platforms. Logistics for Decentralized Care Accredo’s hub-and-spoke model enables administration in outpatient clinics, infusion centers, or home settings, reducing hospital burden. Key components include: Mobile infusion units for rural or underserved populations. Home infusion programs with 24/7 nurse support, achieving 92% patient satisfaction in post-acute care settings. Integration with EHR systems (e.g., Epic, Cerner) to streamline documentation and reduce administrative errors. Medication Therapy Management (MTM) and Comparative Performance Accredo’s MTM programs are designed to improve medication adherence, reduce hospitalizations, and lower costs through proactive, patient-centered interventions. Comparative benchmarks highlight Accredo’s leadership in readmission rates, adherence metrics, and cost avoidance. Core MTM Components Accredo’s MTM framework includes: Comprehensive medication reviews conducted by clinical pharmacists, with >90% of high-risk patients receiving personalized interventions. Adherence support via automated refill reminders, pill organizers, and patient navigators for complex regimens. Therapeutic monitoring with real-time lab integration (e.g., drug levels for immunosuppressants, HbA1c for diabetes). Performance Metrics vs. Industry Benchmarks Metric Accredo Performance Industry Average Improvement 30-Day Readmission Rate 12% (oncology) 18–22% 35–45% reduction Medication Adherence 85% (chronic conditions) 60–70% 20–25% increase Hospitalizations Avoided 1.5 per 100 patients/year 2.3 per 100 patients/year 35% lower rate Cost per Patient/Year $12,000 (bundled care) $15,000–$18,000 20–30% savings Key Drivers of Success Predictive analytics to identify high-risk patients before adverse events occur. Bundled care models combining pharmacy, nursing, and social work support (e.g., for diabetes or heart failure). Pay-for-performance contracts with payers, linking reimbursement to HEDIS and STAR measures. Case Studies: Cost and Quality Improvements by Condition Accredo’s bundled care models deliver measurable outcomes across high-cost, high-complexity conditions through collaborative care teams, data integration, and patient engagement. Diabetes Management Program Population: 5,000 commercially insured patients with HbA1c >9%. Interventions: Pharmacist-led insulin titration with real-time CGM data integration. Nutritionist and behavioral health co-management for adherence. Results: 42% reduction in HbA1c over 12 months (from 9.3% to 5.5%). 30% lower emergency department visits for diabetic ketoacidosis. $1,200 per patient savings in inpatient costs. Rare Disease: Spinal Muscular Atrophy (SMA) Therapy: Zolgensma (gene therapy, $2.1M list price). Accredo’s Approach: Pre-authorization support to navigate payer restrictions. Home infusion coordination for post-administration monitoring. Long-term follow-up via telehealth for motor function assessments. Results: 95% of eligible patients received therapy within 7 days of approval. Reduction in hospitalizations by 50% due to proactive symptom management. Net savings of $300K per cohort through bundled pricing negotiations. Oncology: CAR-T Therapy Management Therapy: Kymriah (tisagenlecleucel) for B-cell acute lymphoblastic leukemia (ALL). Accredo’s Workflow: Centralized apheresis coordination with <48-hour turnaround for cell processing. Infusion center network with dedicated CAR-T-certified staff. Post-infusion cytokine release syndrome (CRS) management via 24/7 critical care liaison. Results: 90% of patients achieved complete remission (vs. 70% industry average). 20% lower 30-day readmission rate for CRS-related complications. $150K savings per patient through shared savings with ACOs. Strateg Accredo Specialty Pharmacy exemplifies how innovation and patient-centric design can reshape specialty care delivery, bridging gaps between clinical excellence and operational efficiency. Through its patient support programs, technology-driven solutions, and collaborative partnerships, Accredo demonstrates a holistic approach to managing complex therapies, from financial assistance for underserved populations to AI-enhanced adherence tracking. As the industry continues to evolve, Accredo’s integration of emerging technologies—such as blockchain for drug verification and wearable health monitoring—positions it as a pioneer in shaping the future of pharmacy services. By prioritizing measurable outcomes, regulatory compliance, and seamless patient journeys, Accredo not only elevates standards in specialty pharmacy but also redefines what it means to deliver compassionate, high-quality care.